Corrigendum to “Evaluation of BCAS1-positive immature oligodendrocytes after cerebral ischemic stroke and SVD” [Neurosci. Lett. 812 (2023) 137405] (Neuroscience Letters (2023) 812, (S0304394023003646), (10.1016/j.neulet.2023.137405))
White matter edematous change with moderate vascular lesions in pretreated acute stage of leukoencephalopathy with cerebral amyloid angiopathy.
Ken Yasuda; Takashi Ayaki; Fangzhou Li; Yasuhiro Kuwata; Takakuni Maki; Makoto Sainouchi; Koki Moriyoshi; Michikazu Nakamura; Ryosuke Takahashi
Neuropathology : official journal of the Japanese Society of Neuropathology, 2022年01月17日
Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations.